These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 25384490)
1. Adolescent vaccine co-administration and coverage in New York City: 2007-2013. Sull M; Eavey J; Papadouka V; Mandell R; Hansen MA; Zucker JR Pediatrics; 2014 Dec; 134(6):e1576-83. PubMed ID: 25384490 [TBL] [Abstract][Full Text] [Related]
2. A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan. Gowda C; Dong S; Potter RC; Dombkowski KJ; Dempsey AF J Adolesc Health; 2013 Oct; 53(4):498-505. PubMed ID: 24054080 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial. Wheeler CM; Harvey BM; Pichichero ME; Simon MW; Combs SP; Blatter MM; Marshall GS; Catteau G; Dobbelaere K; Descamps D; Dubin G; Schuind A Pediatr Infect Dis J; 2011 Dec; 30(12):e225-34. PubMed ID: 21817954 [TBL] [Abstract][Full Text] [Related]
4. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
6. Coadministration of a 9-Valent Human Papillomavirus Vaccine With Meningococcal and Tdap Vaccines. Schilling A; Parra MM; Gutierrez M; Restrepo J; Ucros S; Herrera T; Engel E; Huicho L; Shew M; Maansson R; Caldwell N; Luxembourg A; Ter Meulen AS Pediatrics; 2015 Sep; 136(3):e563-72. PubMed ID: 26240207 [TBL] [Abstract][Full Text] [Related]
7. Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. Kharbanda EO; Stockwell MS; Colgrove J; Natarajan K; Rickert VI Am J Public Health; 2010 Sep; 100(9):1635-40. PubMed ID: 20634463 [TBL] [Abstract][Full Text] [Related]
8. Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States. Vielot NA; Butler AM; Brookhart MA; Becker-Dreps S; Smith JS J Adolesc Health; 2017 Sep; 61(3):281-287. PubMed ID: 28739327 [TBL] [Abstract][Full Text] [Related]
9. Missed opportunities for adolescent vaccination, 2006-2011. Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613 [TBL] [Abstract][Full Text] [Related]
11. The preteen visit: an opportunity for prevention. Campos-Outcalt D J Fam Pract; 2006 Dec; 55(12):1054-6. PubMed ID: 17137541 [TBL] [Abstract][Full Text] [Related]
12. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(34):671-7. PubMed ID: 22932301 [TBL] [Abstract][Full Text] [Related]
13. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017. Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305 [TBL] [Abstract][Full Text] [Related]
14. Vaccination coverage among adolescents aged 13-17 years - United States, 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(40):1100-3. PubMed ID: 18846032 [TBL] [Abstract][Full Text] [Related]
15. Middle school vaccination requirements and adolescent vaccination coverage. Bugenske E; Stokley S; Kennedy A; Dorell C Pediatrics; 2012 Jun; 129(6):1056-63. PubMed ID: 22566425 [TBL] [Abstract][Full Text] [Related]
16. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(34):685-93. PubMed ID: 23985496 [TBL] [Abstract][Full Text] [Related]
17. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data. Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357 [TBL] [Abstract][Full Text] [Related]
18. Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina. Vielot NA; Islam JY; Sanusi B; Myers J; Smith S; Meadows B; Brewer NT; Smith JS Women Health; 2020; 60(10):1129-1140. PubMed ID: 32772834 [TBL] [Abstract][Full Text] [Related]
19. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination. Zimmerman RK; Raviotta JM; Nowalk MP; Moehling KK; Reis EC; Humiston SG; Lin CJ Vaccine; 2017 Oct; 35(45):6180-6186. PubMed ID: 28947346 [TBL] [Abstract][Full Text] [Related]
20. A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016. Irving SA; Groom HC; Dandamudi P; Daley MF; Donahue JG; Gee J; Hechter R; Jackson LA; Klein NP; Liles E; Myers TR; Stokley S Vaccine; 2022 Feb; 40(9):1246-1252. PubMed ID: 35125221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]